Atossa Therapeutics Inc. (NASDAQ: ATOS) closed the day trading at $0.80 up 0.67% from the previous closing price of $0.79. In other words, the price has increased by $+0.0053 from its previous closing price. On the day, 502590 shares were traded. ATOS stock price reached its highest trading level at $0.8000 during the session, while it also had its lowest trading level at $0.7500.
For a better understanding of ATOS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 30.50 and its Current Ratio is at 30.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on January 26, 2018, initiated with a Buy rating and assigned the stock a target price of $2.
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATOS now has a Market Capitalization of 100.10M and an Enterprise Value of -39.94M.
Stock Price History:
Over the past 52 weeks, ATOS has reached a high of $1.39, while it has fallen to a 52-week low of $0.50. The 50-Day Moving Average of the stock is 0.9806, while the 200-Day Moving Average is calculated to be 0.8198.
Over the past 3-months, ATOS traded about 850.33K shares per day on average, while over the past 10 days, ATOS traded about 488.74k shares per day. A total of 125.79M shares are outstanding, with a floating share count of 125.68M. Insiders hold about 0.08% of the company’s shares, while institutions hold 21.50% stake in the company. Shares short for ATOS as of Aug 30, 2023 were 8.2M with a Short Ratio of 8.20M, compared to 8.49M on Jul 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 6.52% and a Short% of Float of 6.52%.
Current recommendations for the stock of the company come from 2 analysts. On average, analysts expect EPS of -$0.07 for the current quarter, with a high estimate of -$0.07 and a low estimate of -$0.07, while EPS last year was -$0.06. The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.07 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.26 and -$0.27 for the fiscal current year, implying an average EPS of -$0.26. EPS for the following year is -$0.26, with 2 analysts recommending between -$0.25 and -$0.28.